Systems and methods of stimulation and activation of fluids for use with instillation therapy

1. A wound treatment system comprising:

a wound dressing;

a fluid storage device configured to deliver a fluid to the wound dressing, the fluid comprising a therapeutic agent; and

an energy source configured to direct energy to the fluid and to activate the therapeutic agent.

2. The wound treatment system of claim 1 , wherein the fluid comprises molecules with a protective coating prior to exposure to the energy source.

3. The wound treatment system of claim 2 , wherein the energy source is configured to degrade the protective coating.

4. The wound treatment system of claim 2 , wherein the energy source is configured to activate a component of the fluid that degrades the protective coating.

5. The wound treatment system of claim 2 , wherein the protective coating comprises a bioabsorbable glass.

6. The wound treatment system of claim 2 , wherein the protective coating comprises a ceramic.

7. The wound treatment system of claim 1 , wherein the energy source emits ultrasonic energy.

8. The wound treatment system of claim 1 , wherein the energy source emits magnetic energy.

9. The wound treatment system of claim 1 , wherein the energy source emits radio frequency energy.

10. The wound treatment system of claim 1 , wherein the energy source emits ionizing radiation energy.

11. The wound treatment system of claim 1 , wherein the energy source emits microwave energy.

12. The wound treatment system of claim 1 , wherein the energy source is configured to direct energy to the fluid proximal to the wound dressing.

13. The wound treatment system of claim 1 , further comprising a conduit in fluid communication with the fluid storage device and the wound dressing.

14. The wound treatment system of claim 13 , wherein the energy source is configured to direct energy to the fluid in the conduit.

15. The wound treatment system of claim 1 , wherein the therapeutic agent comprises property includes an anti-biotic property.

16. The wound treatment system of claim 1 , wherein the therapeutic property includes an analgesic property.

17. The wound treatment system of claim 1 , wherein the therapeutic property aids with debridement of tissue.

18. The wound treatment system of claim 1 , wherein the therapeutic property improves the ability to remove the wound dressing from a wound.

19. The wound treatment system of claim 1 , wherein the therapeutic property reduces biofilm buildup in a wound.

20. A method of treating a wound, the method comprising:

applying a wound dressing to the wound;

providing a fluid storage device and a conduit in fluid communication with the wound dressing;

transporting a fluid to the wound dressing, the fluid comprising a therapeutic agent; and

directing energy to the fluid when the fluid is in the conduit to activate the therapeutic agent.

21. The method of claim 20 , further comprising applying a negative pressure to the wound dressing.

22. The method of claim 20 , further comprising coupling a coupling member to the conduit and the wound dressing.

23. The method of claim 22 , wherein the energy is directed to the fluid at the coupling member.

24. The method of claim 20 , wherein the fluid comprises molecules having a coating and an active agent, and wherein directing energy to the fluid breaks down the coating.

25. A wound treatment system comprising:

a wound dressing;

a fluid storage device in fluid communication with the wound dressing;

a fluid comprising molecules with at least one type of therapeutic agent; and

an energy source configured to direct energy to the fluid to cause activation of the therapeutic agent of the fluid.

26. The wound treatment system of claim 25 , wherein the fluid comprises an anti-microbial agent.

27. The wound treatment system of claim 26 , wherein the anti-microbial agent is hypochlorous acid (HOCl) or hypochlorite ion (ClO − ).

28. The wound treatment system of claim 25 , wherein the fluid further comprises molecules with a protective coating prior to exposure to the energy source.

29. The wound treatment system of claim 28 , wherein the protective coating comprises a plurality of layers of polyallylamine hydrochloride (PAH) and polysodium 4-styrenesulfonate (PSS).

30. The wound treatment system of claim 25 , wherein the molecules include an active agent and are constructed so that the active agent is inhibited by a light-sensitive branch, which when broken, thereby activates the active agent.

31. The wound treatment system of claim 25 , wherein the fluid comprises molecules having an active agent and constructed so that the active agent is controlled by photoinhibition.

32. The wound treatment system of claim 25 , wherein the fluid comprises molecules having an active agent that is a clotting agent.

33. The wound treatment system of claim 32 , wherein the clotting agent is a trivalent salt, such as Fe +++ or Al +++ .

34. The wound treatment system of claim 33 , wherein the Fe +++ compound is encapsulated in a glucose sensitive microcapsule, which increases in permeability to allow for the release of the Fe +++ agent upon encountering glucose.

35. The wound treatment system of claim 25 , wherein the fluid comprises multiple agents which are activated by different wavelengths of light or frequencies of energy.